Pelican Expression Technology Competitors and Similar CompaniesClear all
Pelican Expression Technology's competitors and similar companies include Shandong Saito Biotechnology, Walvax Biotechnology, Serum Institute of India and The Searle Company.
 Pelican Expression Technology Pelican Expression Technology is a platform of Ligand Pharmaceuticals for recombinant protein production. |  Shandong Saito Biotechnology Shandong Saito Biotechnology (山东斋藤生物科技) is a company that is engaged in the research and development and production of steroid drug intermediates. |  Walvax Biotechnology Walvax Biotechnology (also known as Yunnan Watson Biotechnology, 云南沃森生物技术股份有限公司) is a company that is engaged in the research and development, production, and sales of human vaccines and biotechnology drugs. | |||
Founding Date | Founding Date 2009 | Founding Date 2010 | Founding Date 2001 | Founding Date 1966 | Founding Date 1965 |
Type | Type Subsidiary | Type Public | Type Public | Type Subsidiary | Type Private |
Tags | |||||
Locations | Locations San Diego, US HQ | Locations Heze, CN HQ | Locations Kunming, CN HQ | Locations Pune, IN HQ Mumbai, IN Pune, IN | Locations Karachi, PK HQ Karachi, PK Karachi, PK Lahore, PK |
Employees | Employees 14 | Employees 95920% decrease | Employees 2,388 | Employees 5,3831% increase | Employees 2,4241% increase |
Valuation ($) | Valuation ($) N/A | Valuation ($) 708.6 m | Valuation ($) 3.3 b | Valuation ($) N/A | Valuation ($) N/A |
Financial | |||||
Revenue (est.) | Revenue (est.) $50.3m (FY, 2019) | Revenue (est.) ¥961.3m (FY, 2025) | Revenue (est.) ¥2.4b (FY, 2025) | Revenue (est.) N/A | Revenue (est.) N/A |
Cost of goods | Cost of goods $4.9m (FY, 2019) | Cost of goods ¥864.3m (FY, 2025) | Cost of goods ¥615.2m (FY, 2025) | Cost of goods N/A | Cost of goods N/A |
Gross profit | Gross profit $45.4m (FY, 2019) | Gross profit ¥140.3m (FY, 2025) | Gross profit ¥1.8b (FY, 2025) | Gross profit N/A | Gross profit N/A |
Net income | Net income $1.1m (FY, 2019) | Net income (¥84.7m) (FY, 2025) | Net income ¥125.2m (FY, 2025) | Net income N/A | Net income N/A |
Funding | |||||
Total funding raised | Total funding raised $ 24m | Total funding raised N/A | Total funding raised $ 72.8m | Total funding raised N/A | Total funding raised N/A |
For sources of this data, please see the company profile
View Company Profiles
Shandong Saito Biotechnology
HQ
Heze, CN
Employees
959↓ 20% decrease
Shandong Saito Biotechnology (山东斋藤生物科技) is a company that is engaged in the research and development and production of steroid drug intermediates.
View companyWalvax Biotechnology
HQ
Kunming, CN
Employees
2,388
Walvax Biotechnology (also known as Yunnan Watson Biotechnology, 云南沃森生物技术股份有限公司) is a company that is engaged in the research and development, production, and sales of human vaccines and biotechnology drugs.
View company
The Searle Company
HQ
Karachi, PK
Employees
2,424↑ 1% increase
The Searle Company is a pharmaceutical company.
View company